Rosuvastatin Tablets recall — Class II (D-0292-2026) · pharmaranks
Class IIOngoing
Rosuvastatin Tablets recall
FDA recall D-0292-2026 · initiated Dec 31, 2025
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Out of specification for dissolution.
Details
Product
Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15
Recalling company
AvKARE
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Dec 31, 2025
FDA report date
Jan 14, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.